par Dinh, Phuong 
;Harnett, Paul;Piccart-Gebhart, Martine ;Awada, Ahmad
Référence Critical reviews in oncology/hematology, 67, 2, page (103-112)
Publication Publié, 2008-08
;Harnett, Paul;Piccart-Gebhart, Martine ;Awada, Ahmad Référence Critical reviews in oncology/hematology, 67, 2, page (103-112)
Publication Publié, 2008-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Dinh, Phuong; Harnett, Paul; Piccart-Gebhart, Martine; Awada, Ahmad |
| Informations sur la publication: | Critical reviews in oncology/hematology, 67, 2, page (103-112) |
| Statut de publication: | Publié, 2008-08 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Cytotoxic chemotherapy |
| EGFR | |
| Molecularly targeted | |
| Ovarian cancer | |
| VEGF | |
| MeSH keywords: | Antineoplastic Agents -- pharmacology |
| Antineoplastic Agents -- therapeutic use | |
| Female | |
| Humans | |
| Ovarian Neoplasms -- drug therapy | |
| Receptor, Epidermal Growth Factor -- antagonists & inhibitors | |
| Receptors, Platelet-Derived Growth Factor -- antagonists & inhibitors | |
| Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8428 |
| info:doi/10.1016/j.critrevonc.2008.01.012 | |
| info:pii/S1040-8428(08)00024-3 | |
| info:scp/45949104460 | |
| info:pmid/18342536 |
